September 2011
Intermediate to advanced
784 pages
28h 47m
English
Divestitures, Spin-Offs, Carve-Outs, Split-Ups, Split-Offs, and Tracking Stocks
Experience is the name everyone gives to their mistakes.
—Oscar Wilde
Facing the loss of patent protection for its blockbuster drug Plavix, a blood thinner, in 2012, Bristol-Myers Squibb Company decided to split off its 83% ownership stake in Mead Johnson Nutrition Company in late 2009 through an offer to its shareholders to exchange their Bristol-Myers shares for Mead Johnson shares. The decision was part of a longer-term restructuring strategy that included the sale of assets to raise money for acquisitions of biotechnology drug companies ...
Read now
Unlock full access